v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income (loss) $ 4,796 $ (6,500) $ (5,796)
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation of property, plant and equipment 1,649 514 562
Expense of in-process research and development 209
Financial income (expense) related to loan from others 1,278 401 (4,113)
Revaluation of warrants (93) (4,140)
Gain on troubled debt restructuring (14,759)
Share-based compensation 682 1,139 1,602
Decrease (increase) in trade receivables (83)  
Decrease (increase) in other receivables 224 (290) 140
Changes in operating lease right-of-use assets 284 43 153
Increase (decrease) in trade payables (156) (150) (175)
Changes in operating lease liabilities (314) (58) (156)
Increase (decrease) in other payables 157 (341) 309
Net cash used in operating activities (6,335) (9,382) (7,265)
Cash flows from investing activities:      
Purchase of property, plant and equipment (12) (637) (836)
Net cash used in investing activities (12) (637) (836)
Cash flows from financing activities:      
Proceed from exercise of warrants, net 1,441 947 5,844
Proceeds from issuance of shares, net 2,000 139 932
Net cash provided by financing activities 3,441 1,086 6,776
Effect of exchange rate changes on cash, cash equivalents and restricted cash (9) (272) (1,977)
Increase (decrease) in cash, cash equivalents and restricted cash (2,915) (9,205) (3,302)
Cash, cash equivalents and restricted cash at beginning of year 5,010 14,215 17,517
Cash, cash equivalents and restricted cash at end of year 2,095 5,010 14,215
(1) Cash paid during the year for:      
Interest 143 833 916
(2) Non-cash transactions:      
Recognition of right-of-use assets and lease liabilities upon exercise of lease extension option 952
Reclassification of warrants liability to equity 398
Loan convert into preferred shares 5,627  
Exercise of warrants liability into shares 801 250
Reconciliation of cash, cash equivalents and restricted cash:      
Cash and cash equivalents 1,964 4,870 14,075
Restricted cash 131 140 140
Cash, cash equivalents and restricted cash $ 2,095 $ 5,010 $ 14,215